Microglial cells are representatives of the immune system in the CNS parenchyma. Their most characteristic property is their ability to modify their behavior in response to diverse signals from other cells in a variety of experimental conditions and human diseases, both acute and chronic. The transformation from a quiescent state into phagocytic brain macrophages is under strict control and accompanied by the production of several secretory products. These include cytokines, excitatory amino acids, and reactive oxygen metabolites by which the activated microglial cells correspond with other cells of the brain and immune system. Thus, they represent an essential host defense and repair system, and may be responsible for tissue destruction and neuronal death, depending on the balance of activating and inhibitory signals. NEUROSCIENTIST 2:293-299, 1996
Ling EA, Wong WCThe origin and nature of ramified and amoeboid microglia. A historical review and current concepts. Glia1993;7:9-18.
2.
Graeber MB, Streit WJMicroglia: immune network in the CNS. Brain Pathol1990;1:2-5.
3.
Perry VH, Gordon S.Macrophages and the nervous system. Int Rev Cytol1991;125:203-244.
4.
Perry VH, Andersson P-B., Gordon S.Macrophages and inflammation in the central nervous system. Trends Neurosci1993;7: 268-273.
5.
Celada A., Nathan C.Macrophage activation revisited. Immunol Today1994;15:100-102.
6.
Frei K., Piani D., Pfister HW, Fontana A.Immune mediated injury in bacterial meningitis. Int Rev Exp Pathol1993;34(Pt B):183-192.
7.
Giulian D., Ingemann JEColony stimulating factors as promotors of ameboid micoglia. J Neurosci1988;85:317-321.
8.
Imamura K., Suzumura A., Sawada M., Mabuchi C., Marunouchi T.Induction of MHC class II antigen expression on munne microglia by interleukin 3. J Neuroimmunol1994;55:119-125.
9.
Frei K., Bodmer S., Schwerdel C., Fontana A.Astrocyte derived interleukm 2 as a growth factor for microglial cells and peritoneal macrophages. J Immunol1986 ;137:3521-3527.
10.
Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A.Antigen presentation and tumor cytotoxicity by interferon-g-treated microglial cells. Eur J Immunol1987;17:1271-1278.
Rosen GM, Pou S., Ramos CL, Cohen MS, Bntigan BEFree radicals and phagocytic cells. FASEB J1995;9:200-209.
13.
Gehrmann J. , Bonnekoh P., Miyazawa T., Hossmann K-A., Kreutzberg GWImmunocytochemical study of an early microglial activation m ischemia. J Cereb Blood Flow Metab1992;12:257-269.
14.
Fmsen BR, Jørgensen MB, Diemer NH, Zimmer J.MHC antigen expression after ischemic and kianic acid lesions of the adult rat hippocampus. Glia1993;7:41-49.
15.
Giulian D., Vacca K.Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke1993; 24 Suppl I:S184-S190.
16.
Andersson PB , Perry VH, Gordon S.The kinetics and morphologic characteristics of the macrophage-microglia response to kianic acid-induced neuronal degeneration . Neuroscience1991;42: 201-214.
17.
Coffey PJ, Perry VH, Rawlins Jnp.An investigation into the early stages of the inflammatory response following ibotenic acid induced neuronal degeneration. Neuroscience1990;35:121-132.
18.
Graeber MB, Streit WJ, Kreutzberg GWAxotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res1988;21:18-24.
19.
Streit WJ, Graeber MB, Kreutzberg GWPeripheral nerve lesion produce increased levels of major histocompatibility complex antigens in the central nervous system. J Neuroimmunol1989;21: 117-123.
20.
Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C.Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia1993 ;7:75-83.
21.
McGeer PL, Kawamata T., Walker DG, Akioyma H., Tooyama I., McGeer EGMicroglia in degenerative neurological disease. Glia1993;7:84-92.
22.
Lassmann H. , Schied M., Vass K., Hickey WFBone marrow derived elements and resident microglia in brain inflammation. Glia1993 ;7:19-24.
23.
Perry H., Gordon S.Macrophages and microglia in the nervous system. Trends Neurosci1988;11:273-277.
24.
Andersson PB , Perry VH, Gordon S.The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience1992;48:169-186.
25.
Huitinga I. , Rooijen N., Groot Cja, Uitdehaag Bmj, Dijkstra Cde.Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med1990;172:1025-1033.
26.
Gehrmann J. , Gold R., Linnington C., Lannes-Vieira J., Wekerle H., Kreutzberg GWSpinal cord microglia in experimental allergic neuritis. Lab Invest1992;67:100-112.
27.
Matsushima GK, Taniike M., Glimcher LH, et al. Absence of MHC class II molecules reduces CNS demyelination microglial/ macrophage infiltration, and twiching in munne globoid cell leukodystrophy. Cell1994;78:645-656.
28.
Malipiero U. , Frei K., Fontana A.Production of hematopoietic colony stimulating factors by astrocytes. J Immunol1990;144:3816-3821.
29.
Nohava K., Malipiero U., Frei K., Fontana A.Neurons and neuroblastoma as a source of macrophage colony-stimulating factor . Eur J Immunol1992;22:2539-2545.
30.
Raivich G., Moreno-Flores MT, Moller JC, Kreutzberg GWInhibition of posttraumatic microglial proliferation m a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur J Neurosci1994;6:1615-1618.
31.
Vangun A., Farber JAIFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-Aα, in astrocytes and microglia. J Immunol1994;152:1411-1418.
32.
Ransohoff RM , Hamilton TA, Tani M., et al. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis . FASEB J1993;7:592-597.
33.
Hayashi M., Luo Y., Laning JH, Strieter R., Dorf MEProduction and function of monocyte chemoattractant protein-1 and other β-chemokines in munne glial cells. J Neuroimmunol1995;60:143-150.
34.
Hartung H-P. , Heininger K., Toyka KVPrimary astroghal cultures can generate leukotriene B4. J Neuroimmunol1988;19:237-243.
35.
Klegeris A. , Walker DG, McGeer PLActivation of macrophages by Alzheimer β amyloid peptide. Biochem Biophys Res Commun1994;199:984-991.
36.
Meda L., Cassatella MA, Szendrei GI, et al. Activation of microglial cells by β-amyloid potem and interferon γ. Nature1995;374: 647-649.
37.
Kettenmann H., Banati R., Walz W.Electrophysiological behavior of microglia . Glia1993;7:93-101.
38.
Lee SC, Liu W., Dickson DW, Brosnan CF, Berman JWCytokine production by human fetal microglia and astrocytes. J Immunol1993;150:2659-2667.
39.
Frei K., Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A.On the cellular source and function of interleukm 6 produced in the central nervous system in viral disease. Eur J Immunol1989;19:689-694.
40.
Levine B., Hardwick JM, Trapp BD, Crawford TO, Bollinger RC, Griffin DEAntibody-mediated clearance of alphavirus infection from neurons. Science1991;254:856-860.
41.
Spranger M. , Lindholm D., Bandtlow C., et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur J Neurosci1989;2:69-76.
42.
Bandtlow C. , Meyer M., Lindholm D., Spranger M., Heumann R., Thoenen H.Regional and cellular codistnbution of interleukin 1β and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol1990;111:1701-1711.
43.
Sebire G., Hery C., Peudenier S., Tardieu M.Adhesion proteins on human microglial cells and modulation of their expression by IL-1α and TNFα. Res Virol1993;144:47-52.
44.
Giulian D., Robertson C.Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol1990;27: 3342.
45.
Renno T., Krakowski M., Piccirillo C., Lin J., Owens T.TNFα expression by resident microglia and infiltrating leukocytes m the central nervous system of mice with experimental allergic encephalomyelitis . J Immunol1995;154:944-953.
46.
Selmaj JW, Rame CSTumor necrosis factor mediates myelin and oligodendrocyte damage in vitro . Ann Neurol1988;23:339-346.
47.
Colton CA, Snell J., Chernyshev O., Gilbert DLInduction of superoxide anion and nitric oxide production in cultured microglia . Ann N Y Acad Sci1994;738:54-63.
48.
Nguyen R., Brunson D., Crespi CL, Penman BW, Wishnok JS, Tannenbaum SRDNA damage mutation in human cells exposed to nitric oxide in vitro . Proc Natl Acad Sci U S A1992;89:3030-3034.
49.
Merrill JE, Ignarro LJ, Sherman MP, Melinek J., Lane TEMicroglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol1993;151:2132-2141.
50.
Chao CC, Hu S., Molitor TW, Shaskan EG, Peterson PKActivated microglia mediate neuronal cell injury via a nitric oxide mechanism . J Immunol1992;149:2736-2741.
51.
Tsunawki S. , Sporn M., Aihao D., Nathan C.Deactivation of macrophages by transforming growth factor-β. Nature1988;334:260-262.
52.
Thery C., Chamak B., Mallat M.Cytotoxic effect of brain macrophages on developing neurons. Eur J Neurosci1991;3:1155-1164.
Piani D., Spranger M., Frei K., Schaffner A., Fontana A.Macrophage-induced cytotoxicity of NMDA receptor positive neurons involves excitatory ammo acids rather than reactive oxygen intermediates and cytokines . Eur J Immunol1992;22:2429-2436.
55.
Piani D., Frei K., Do KQ, Cuenod M., Fontana A.Munne brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett1991 ;133:159-162.
56.
Giulian D., Vaca K., Noonan CASecretion of neurotoxins by mononuclear phagocytes infected with HIV-1 . Science1990;250:1593-1596.
57.
Giulian D., Wendt E., Vaca K., Noonan C.The envelope glycoprotein of HIV-1 stimulates monocyte release of neurotoxms . Proc Natl Acad Sci U S A1993 ;90:2769-2773.
58.
Lipton AS, Sucher NJ, Kaiser PK, Dreyer EBSynergistic effect of HIV coat protein and NMDA receptor-mediated neurotoxicity . Neuron1991;7:111-118.
59.
Lipton ALModels of neuronal injury in AIDS. Another role for the NMDA receptors . Top Neurosci1993;15:75-79.
60.
Suzumura A. , Sawada M., Yamamoto H., Marunouchi T.Transformmg growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol1993;151:2150-2158.
61.
Frei K., Lms H., Schwerdel C., Fontana A.Antigen presentation in the central nervous system. The inhibitory effect of Il-10 on MHC class II expression and production of cytokine depends on the inducing signals and the type of cell analyzed. J Immunol1994; 152:2720-2728.
62.
Chao CC, Molitor TW, Hu S.Neuroprotective role of IL-4 against activated microglia. J Immunol1993;151:1473-1481.
63.
Vodovotz Y. , Bogdan C., Paik J., Xie Q., Nathan C.Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β . J Exp Med1993;178:605-613.
64.
Pfister HW, Frei K., Ottnad B., Koedel U., Tomasz A., Fontana A.Transforming growth factor beta 2 inhibits cerebrovascular changes and brain edema formation in the tumor necrosis factor alpha-independent early phase of experimental pneumococcal menimgis. J Exp Med1992;176:265-268.
65.
Piani D., Fontana A.Involvement of the cystine transport system xc- in the macrophage-induced glutamate dependent cytotoxicity to neurons. J Immunol1994;152:3578-3584.
66.
Cash E., Mmty A., Ferrara P., Caput D., Fradehzi D., Rott O.Macrophage inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol1994;153:4258-4267.
67.
Rodriguez M. , Pavelko KD, McKinney CW, Leibowtiz JLRecombmant human IL-6 supresses demyelination in a viral model of multiple sclerosis . J Immunol1994;153:3811-3821.
68.
Wesselingh SL, Levine B., Fox RJ, Choi S., Griffin DEIntracerebral cytokine mRNA expression during fatal and nonfatal alphavirus suggests a predominant type 2 T cell response . J Immunol1994; 152:1289-1297.
69.
Li H., Newcombe J., Groone NP, Cuzner MLCharacterization and distribution of phagocytic macrophages in multiple sclerosis plaques. Neuropathol Appl Neurobiol1993;19:214-223.
70.
Hofman FM, Hinton DR, Johnson K., Memll JETumor necrosis factor α identified in multiple sclerosis brain . J Exp Med1989; 170:607-612.
71.
Boyle EA, McGeer PLCellular immune response in multiple sclerosis plaques. Am J Pathol1990;137:575-584.
72.
Brew BJThe clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy. Curr Opin Neurol1994;7:209-216.
73.
Heyes MP, Brew BJ, Martin A., Price PL, et al. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann Neurol1991;29:202-209.
74.
Perlmutter LS, Barron E., Chui HCMorphologic association between microglia and senile plaque amyloid in Alzheimer's disease. Neurosci Lett1990; 119:32-36.
75.
Banati RB, Gehrmann J., Czech C., et al. Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia1993;9:199-210.
